Sinclair Pharma (XPAR:SPH) EV-to-Revenue : 2.54 (As of May. 25, 2024)

View and export this data going back to . Start your Free Trial

What is Sinclair Pharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sinclair Pharma's enterprise value is €134.12 Mil. Sinclair Pharma's Revenue for the trailing twelve months (TTM) ended in Jun. 2018 was €52.80 Mil. Therefore, Sinclair Pharma's EV-to-Revenue for today is 2.54.

The historical rank and industry rank for Sinclair Pharma's EV-to-Revenue or its related term are showing as below:

XPAR:SPH' s EV-to-Revenue Range Over the Past 10 Years
Min: 1 Med: 2.4 Max: 9.8
Current: 3.86

During the past 13 years, the highest EV-to-Revenue of Sinclair Pharma was 9.80. The lowest was 1.00. And the median was 2.40.

XPAR:SPH's EV-to-Revenue is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.285 vs XPAR:SPH: 3.86

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-25), Sinclair Pharma's stock price is €0.27. Sinclair Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2018 was €0.13. Therefore, Sinclair Pharma's PS Ratio for today is 2.14.

Sinclair Pharma EV-to-Revenue Historical Data

The historical data trend for Sinclair Pharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma EV-to-Revenue Chart

Sinclair Pharma Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Dec17

EV-to-Revenue

Get a 7-Day Free Trial

2.29

2.24

3.09

8.55

2.96

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
EV-to-Revenue	Get a 7-Day Free Trial															-	-	-	2.96	-

Competitive Comparison of Sinclair Pharma's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Sinclair Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinclair Pharma's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sinclair Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sinclair Pharma's EV-to-Revenue falls into.

Sinclair Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sinclair Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	134.117	/	52.795
	=	2.54

Sinclair Pharma's current Enterprise Value is €134.12 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinclair Pharma's Revenue for the trailing twelve months (TTM) ended in Jun. 2018 was €52.80 Mil.

Sinclair Pharma (XPAR:SPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sinclair Pharma's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.27	/	0.126
	=	2.14

Sinclair Pharma's share price for today is €0.27.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2018 was €0.13.

Sinclair Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sinclairispharma.com

Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.